Evidence map›Paper›PMID 32439490›Full record

ArticleTransfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis2020

Characterization of circulating and cultured Tfh-like cells in sickle cell disease in relation to red blood cell alloimmunization status.

Raisa Balbuena-Merle, Manjula Santhanakrishnan, Lesley Devine, David R Gibb, Christopher A Tormey, Alexa J Siddon, Susanna A Curtis, Patrick G Gallagher, Jason S Weinstein, Jeanne E Hendrickson

Abstract read
In one paragraph

Article in Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. The Immunology of Transfusion Medicine: Past, Present, and Future.Methods in molecular biology (Clifton, N.J.) · 2026
    Review
  3. Review
  4. Divergent CD4Frontiers in immunology · 2023
    Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Raisa Balbuena-MerleYale University, Department of Laboratory Medicine, New Haven, CT, United States.
Manjula SanthanakrishnanYale University, Department of Laboratory Medicine, New Haven, CT, United States.
Lesley DevineYale University, Department of Laboratory Medicine, New Haven, CT, United States.
David R GibbCedars-Sinai Medical Center, Department of Pathology and Laboratory Medicine, Los Angeles, CA, United States.
Christopher A TormeyYale University, Department of Laboratory Medicine, New Haven, CT, United States; VA Connecticut, Pathology and Laboratory Medicine Service, West Haven, CT, United States.
Alexa J SiddonYale University, Department of Laboratory Medicine, New Haven, CT, United States; VA Connecticut, Pathology and Laboratory Medicine Service, West Haven, CT, United States; Yale University, Department of Pathology, New Haven, CT, United States.
Susanna A CurtisYale University, Division of Hematology/Oncology, New Haven, CT, United States.
Patrick G GallagherYale University, Department of Pathology, New Haven, CT, United States; Yale University, Department of Pediatrics, New Haven, CT, United States; Yale University, Department of Genetics, New Haven, CT, United States.
Jason S WeinsteinRutgers New Jersey Medical School, Center for Immunity and Inflammation, Newark, NJ, United States.
Jeanne E HendricksonYale University, Department of Laboratory Medicine, New Haven, CT, United States; Yale University, Department of Pediatrics, New Haven, CT, United States. Electronic address: jeanne.hendrickson@yale.edu.

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Yale Pathology Tissue Services Shared ResourceP30CA016359 · NCI · YALE UNIVERSITY · PI MEGAN C KING · 1985 to 2026
$85.0M
Yale Cooperative Hematology Specialized Core CenterU54DK106857 · NIDDK · YALE UNIVERSITY · PI JOHN HWA, Diane S Krause · 2015 to 2026
$9.7M
IMMUNOHEMATOLOGY/TRANSFUSION MEDICINE RESEARCH TRAININGT32HL007974 · NHLBI · YALE UNIVERSITY · PI JEANNE E HENDRICKSON, Diane S Krause · 2001 to 2026
$8.1M
Cis Regulatory Elements and Systemic Lupus ErythematosusR01AR068994 · NIAMS · YALE UNIVERSITY · PI CRAFT, JOSEPH EDGAR, GALLAGHER, PATRICK G · 2016 to 2020
$2.7M
Protecting Fetuses and Newborns from Maternal RBC AlloantibodiesR01HL126076 · NHLBI · YALE UNIVERSITY · PI HENDRICKSON, JEANNE E · 2014 to 2018
$2.1M
Responsiveness and non-responsiveness to transfused RBCs in mice and humans.R01HL132951 · NHLBI · YALE UNIVERSITY · PI GALLAGHER, PATRICK G · 2017 to 2020
$1.7M
The role of type 1 interferon in regulating alloimmune responses to transfused red blood cellsK08HL141446 · NHLBI · CEDARS-SINAI MEDICAL CENTER · PI GIBB, DAVID R · 2018 to 2022
$820k
NCATS NIH HHS UL1 TR001863NCI NIH HHS P30 CA016359NHLBI NIH HHS K08 HL141446NHLBI NIH HHS R01 HL126076NHLBI NIH HHS R01 HL132951NHLBI NIH HHS T32 HL007974NIAMS NIH HHS R01 AR068994NIDDK NIH HHS U54 DK106857
6 · The paper itself

Abstract

backgroundPeople living with sickle cell disease (SCD) are prone to red blood cell (RBC) alloimmunization. We hypothesized that subjects with alloantibodies (responders) would have differences in circulating T-follicular helper (Tfh)-like cells compared to subjects without alloantibodies (non-responders). MATERIALS AND

methodsPeripheral blood mononuclear cells were collected from 28 subjects, including those with SCD and controls. Circulating CD4 T-cell subsets were first evaluated at baseline. CD4 T-cell subsets were also evaluated after naïve CD4 T-cells were differentiated into Tfh-like cells following in vitro culture with CD3/CD28 beads, IL-7, IL-12, and Activin A. Transfusion and alloantibody histories were extracted from the electronic medical record.

resultsNon-responders had a lower percentage of CD45RA negative Tmemory cells than responders or controls (p<0.05). Notably, there were no differences in circulating Tfh-like cells between any group. However, naïve CD4 T-cells from subjects with SCD were more likely to express CXCR5 after in vitro culture than cells from controls. After culture, CXCR5 expressing cells from responders were more likely to express PD1 and ICOS (16.43 %, sd. 20.23) compared to non-responders (3.69 %, s.d. 3.09) or controls (2.78 %, s.d. 2.04). DISCUSSION: The tendency for naïve CD4 T-cells from responders to differentiate into Tfh-like cells after in vitro culture may suggest these cells are prepared to assist B-cells with antibody production regardless of antigen specificity. Further studies are needed, but it is possible that these results may explain why some responders form RBC alloantibodies with multiple specificities, in addition to RBC autoantibodies and HLA alloantibodies.

Indexed as

AdultAnemia, Sickle CellErythrocyte TransfusionFemaleHumansMaleT-Lymphocyte SubsetsTransfusion MedicineRed blood cell alloimmunizationSickle cell diseaseTfh-like cellsTransfusion medicine

Identifiers

PMID32439490
PMCPMC7483805

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.